Ritu Gilhotra Editor

Dr. Gaurav Gupta holds a doctoral degree from Pacific University, Udaipur, Rajasthan, India. With over nine years of experience in molecular and biochemical pharmacology, encompassing phytochemistry, respiratory diseases, psychopharmacology, and cancer biology, he utilizes experimental animal models to elucidate cellular and molecular mechanisms. Dr. Gupta is dedicated to enhancing healthcare outcomes through his initiatives in pharmacology and phytochemistry research, as well as his effective teaching in the field of pharmaceutical sciences.

Currently, Dr. Gupta serves as an Associate Professor at Suresh Gyan Vihar University, Jaipur, Rajasthan, India. He has authored over 200 research and review articles in national and international journals of high repute.

Dr. Md. Sadique Hussain currently serves as an assistant professor at Jaipur National University, where he also completed his Master of Pharmacy (pharmacology). He is currently pursuing his PhD in pharmaceutical sciences. With a prolific and accomplished writing career, his diverse portfolio boasts numerous peer-reviewed manuscripts, research papers, and thought-provoking book chapters. Possessing a passion for knowledge and a keen eye for detail, Md. Sadique Hussain delves into various subjects, leaving an indelible mark on academia and beyond. His dedication to crafting insightful content and fostering intellectual curiosity has garnered admiration from peers and readers alike.

Dr. Kamal Dua is a senior lecturer in the discipline of pharmacy at the Graduate School of Health, University of Technology Sydney (UTS). With over 12 years of research experience, he has specialized in drug delivery targeting inflammatory diseases. Additionally, Dr. Dua serves as the Node Leader of Drug Delivery Research in the Center for Inflammation at the Centenary Institute/UTS. In this role, he focuses on advancing targets identified in research projects to develop innovative formulations, taking the first steps toward clinical translation. Dr. Dua's research encompasses two complementary areas: drug delivery and immunology. His work explores how these disciplines can mutually benefit, contributing to the goal of promoting longer and healthier lives for the community. This commitment to synergy is reflected in his extensive publication record in reputable journals. Dr. Dua's research interests are centered on harnessing the pharmaceutical potential of modulating critical regulators, such as interleukins and microRNAs. He also specializes in developing new and effective drug delivery formulations for managing inflammation in chronic airway diseases and cancer.

Dr. Ritu Gilhotra currently holds the position of ProPresident at SGVU and serves as a Professor and Dean at Gyan Vihar School of Pharmacy. She earned her Master's and Doctorate degrees in Pharmaceutics from the Faculty of Pharmacy at GJUST, Hisar, with a notable research output in the area of ocular drug delivery systems for the management of glaucoma. Prof. Gilhotra's primary research interest revolves around advanced drug delivery systems (DDSs) and drug targeting, in addition to pharmaceutical formulation and dosage form design. Within the realm of DDSs, her work focuses on formulating and evaluating innovative nanoparticles, microparticulates, and vesicular drug carriers aimed at targeting specific biological sites. Dr. Gilhotra has a substantial body of work to her credit, including book chapters and over 100 research articles published in indexed and peer-reviewed journals across the fields of pharmaceutics, pharmacy education, and pharmacy practice. Furthermore, she has obtained 10 patents, 2 industrial designs, and facilitated 1 technology transfer.

Professor Murali Dhanasekaran currently holds the position of Director of International Programs at Auburn University's Harrison College of Pharmacy. As a distinguished educator and scientist, he embarked on his academic journey with a B.Pharm from Annamalai University, furthering his education with an M.Pharm from Jadavpur University, and ultimately obtaining a Ph.D. from the Indian Institute of Chemical Biology. His post-doctoral research led him through various institutions, including the University of Nebraska Medical Center, the University of North Dakota, and Texas A&M. During his tenure at Auburn, Murali has played a transformative role in pharmaceutical education. He not only teaches a diverse range of courses but also initiated an undergraduate program in drugs and biopharmaceutical sciences. His dedication to nurturing global academic relationships is evident in his collaborations with institutions in more than 15 countries. Murali's laboratory has been at the forefront of neuroscientific research, pioneering the development of various models to comprehend neurological disorders and explore the therapeutic potential of both synthetic and natural bioactives. With a remarkable portfolio of over 125 research articles, 55 book chapters, and 7 books, his work has gained significant recognition, particularly his research on the neuroprotective effects of Centella asiatica in Alzheimer's disease. Presently, his research ambitiously delves into groundbreaking drug development for major neurological ailments, the effects of designer drugs, and the intricate interplay between chemotherapy and neurological health.